A Study of SEA-CD40 Given With Other Drugs in Cancers
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
Assessing the Tolerance and Clinical Benefit of feCAl tranSplantation in patientS With melanOma
- Status
- COMPLETED
- Phase
- PHASE2
Using QPOP to Predict Treatment for Sarcomas and Melanomas
- Status
- RECRUITING
- Phase
- N/A
Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2
Camrelizumab Plus Amlotinib and Chemotherapy in the First-line Treatment of Melanoma
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Dapansutrile Plus Pembrolizumab in Patients With PD-1 Refractory Advanced Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Adjuvant Dabrafenib and Trametinib Treatment in Patients With Completely Resected High-risk Stage III Melanoma.
- Status
- COMPLETED
- Phase
- N/A
Pembrolizumab and Lenvatinib in Patients With Brain Metastases From Melanoma or Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
NeoVax + CDX-301 and Nivolumab or Pembrolizumab in Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
SYSTEMATIC SYMPTOM ASSESSMENT IN CANCER PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS
- Status
- UNKNOWN
- Phase
- NA
Evaluation of Cytokine Biomarkers in Melanoma Patients During Immunotherapy
- Status
- UNKNOWN
- Phase
- PHASE2
Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
REduced Frequency ImmuNE Checkpoint Inhibition in Cancers
- Status
- UNKNOWN
- Phase
- PHASE2
Troriluzole or Placebo Plus Ipi Plus Nivo in Mel Brain Mets
- Status
- TERMINATED
- Phase
- PHASE2
Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Evaluation of Different Smoking Cessation Protocols: Nicotine Replacement, Motivational Interviewing (MI), Cognitive Behavioural Therapy (CBT) or Hypnotherapy in Cancer Patients Scheduled for Surgery
- Status
- TERMINATED
- Phase
- NA
B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
- Status
- RECRUITING
- Phase
- PHASE1
A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
The Effect of Diet and Exercise on ImmuNotherapy and the Microbiome (EDEN)
- Status
- SUSPENDED
- Phase
- NA